Acridorex | |
---|---|
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 340.5 g/mol [1] |
Predicted LogP | 5.7 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C24H24N2 [1] |
IUPAC name | N-(2-acridin-9-ylethyl)-1-phenylpropan-2-amine [1] |
SMILES | CC(CC1=CC=CC=C1)NCCC2=C3C=CC=CC3=NC4=CC=CC=C42 [1] |
InChI | InChI=1S/C24H24N2/c1-18(17-19-9-3-2-4-10-19)25-16-15-20-21-11-5-7-13-23(21)26-24-14-8-6-12-22(20)24/h2-14,18,25H,15-17H2,1H3 [1] |
InChIKey | SZSWKYIWACGNDZ-UHFFFAOYSA-N [1] |
Acridorex
Acridorex (also known as B. S. 7573-a, B.S. 7573-a, 9-Acridineethanamine, N-(1-methyl-2-phenylethyl)-, BS-7573-A, 9-(2-((α-Methylphenethyl)amino)ethyl)acridine, 9-{2-((α-Methylphenethyl)amino)ethyl}acridine, Acridorexum, BS 7573-a, HY-164022 or CS-1097708) is a stimulant substance of the amphetamine class.
Chemistry
Stereochemistry []
Acridorex is a racemic mixture of the enantiomers
Stereoisomers |
---|
Subjective effects
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 297931, Acridorex. Accessed July 20, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/297931
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Acridorex. UNII: 7SGV5HQH8B. Global Substance Registration System. Accessed July 20, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/7SGV5HQH8B